MedTrace Logo

Microneedling Therapy With or Without Amnion Bilayer Sheeting on Scar Tissue

NCT04995302 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2021-08-06

No results posted yet for this study

Summary

The aim of this study is to compare the outcome of microneedling therapy with or without amnion bilayer sheeting on post-burn hypertrophic scar tissue. A clinical trial will be conducted with 17 samples, from September to December 2021.

Conditions

  • Scars, Hypertrophic
  • Burn Scar

Interventions

PROCEDURE

Microoneedling and Amnion Bilayer

Microneedling is conducted following a three-week application of tretinoin cream. Then, scar tissue that has been treated with microneedling is covered with amnion bilayer for 72 hours.

PROCEDURE

Microoneedling

Microneedling is conducted following a three-week application of tretinoin cream. Then, scar tissue that has been treated with microneedling is covered with an antibacterial gauze dressing.

Sponsors & Collaborators

  • Dr.dr.Irma Bernadette, SpKK (K)

    lead OTHER

Principal Investigators

  • Irma B Sitohang · Fakultas Kedokteran Universitas Indonesia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2021-12-30
Completion
2022-01-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04995302 on ClinicalTrials.gov